An online crowdfunder has been launched to kickstart a key campaign to generate awareness of prescription cannabis among the general public. The crowdfunder, being run by the Cannabis Industry Council (CIC), aims to raise £20,000 initially to undertake public relations and promotional activity around the existence [...]
A new paper highlights the need for greater public health messaging around the risks of cannabis use disorders among those prescribed it for medicinal purposes. While cannabis can have a wide range of potential therapeutic benefits, like any drug or medication it can have adverse effects [...]
Online medical cannabis clinic, Treat It, has announced its expansion to include specialised psychiatric services amid the UK’s ‘mental health crisis’. The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Kanabo Group’s digital health platform, at a time [...]
In August 2023 I was relaxing by the seafront in Plymouth with my sister on what should have been a pleasant day. Instead, around 10 minutes after taking my medication, two police officers arrived who refused to accept my medication was legal and proceeded to detain me for 6 hours. Following my arrest I realised just how widespread the challenges facing medical cannabis patients were and decided to join PatientsCann UK. After my release, Devon & Cornwall Police admitted they were “ill equipped to deal with patients lawfully in possession of cannabis”. I liaised with the Diverse Community and Serious Organised Crime Branches where they have confirmed the force are implementing a number of packages, including training for frontline police officers in being able to identify genuine medicinal cannabis patients and clarification that a medical cannabis card is not required. Despite the implementation of these packages, there are still a number of challenges that remain for medical cannabis patients, one such example is driving. Devon & Cornwall Police advised “If a positive test is obtained it is likely to lead to the arrest and detention of the driver on suspicion of being ‘unfit to drive through drink or drugs (S.5 RTA)’. Not until the individual has been through the ‘police custody experience’ would any lawfully defence such as a prescription be considered.” Devon & Cornwall Police were open for further engagement on these challenges, so I got in contact with Guy Coxall from Seed our Future. Guy is a court expert on Cannabis and the Road Traffic Act, and lead author on the Cannabis Industry Council guidance on Cannabis and Driving. He was very happy to join the discussions. I got back in touch with the force and a meeting was arranged at their Headquarters in Exeter on 4th January 2024. At the meeting we were joined by a number of stakeholders from Devon & Cornwall Police including a Drug Expert Witness, Diverse Communities Officer, Road Traffic Officer and Drug Impairment Lead. Guy did a presentation on the Road Traffic Act and Swab Tests which generated a number of interesting discussions. In addition we touched on a number of other issues facing medical cannabis patients such as discrimination and hate crime risk, and employees of the force using their medication. We also received a number of interesting updates including the training package Devon & Cornwall Police developed being shared with 18 police forces, and processes being put in place so people in police custody can use their legally prescribed medication. Devon & Cornwall Police will share a report on their work so far. In the end we didn’t have time to discuss all points, and I think we all came away with more questions than answers! But the day set a foundation for future work with Devon & Cornwall Police, and PatientsCann UK and Seed Our Future will continue to work with the Force to address these issues. Our hope is that this work will continue to spread beyond Devon and Cornwall across the UK for the benefit of all patients. Authored by – Sal Aziz
The post PatientsCann and Seed our Future Begin Work with Local Police first appeared on PatientsCann UK.
Empowering Patients Worldwide We are thrilled to announce a significant milestone for PatientsCann UK – our appointment as the UK representative to the International Alliance for Cannabinoid Medicines (IACM) Patients Council. This prestigious position marks a new chapter in our commitment to advocating for patient rights and fostering collaboration on a global scale. About IACM Patients Council The IACM Patients Council is a dynamic coalition of patient organisations from around the world. Its primary objective is to provide a unified voice for patients in the rapidly evolving landscape of medicinal cannabis. By working collectively, these organisations aim to safeguard the rights and interests of patients and ensure their perspectives are integral to the ongoing developments in medicinal cannabis. Our Role as the UK Representative As the UK representative to the IACM Patients Council, PatientsCann is honoured to take on the responsibility of championing the concerns, aspirations, and needs of patients in the United Kingdom. This role aligns seamlessly with our core mission of promoting a patient-centric approach to medical cannabis advocacy. Key Focus Areas Global Collaboration: We look forward to actively engaging with patient organisations worldwide. By fostering international collaboration, we can share insights, best practices, and advocate for the common goal of improving patient access and rights. Information Exchange: Our role involves facilitating the exchange of information between patients, organisations, and key stakeholders. By doing so, we aim to contribute to the creation of a well-informed and empowered patient community. Advocacy and Education: Through our representation, we will advocate for policies that prioritise patient well-being. Education will be a focal point, ensuring that patients are equipped with the knowledge to make informed decisions about their healthcare. PatientsCann’s Commitment Our journey with the IACM Patients Council is not just about representation; it’s about effecting positive change. PatientsCann is committed to leveraging this opportunity to enhance the dialogue surrounding medicinal cannabis, challenge stigmas, and drive initiatives that benefit patients globally. We express our gratitude to our supporters, volunteers, and the entire medical cannabis community. Your encouragement has been instrumental in reaching this milestone. Together, let’s continue advancing patient-centric approaches to medical cannabis and shaping a more compassionate and informed world. Empowering Patients, Transforming Lives.
The post PatientsCann UK Appointed UK Representative to IACM Patients Council first appeared on PatientsCann UK.
We are thrilled to share some exciting news! PatientsCann UK is a proud member of the National Council for Voluntary Organisations (NCVO). This is a significant step forward in our journey of advocating for patient rights and fostering positive change in the medical cannabis landscape. Understanding the NCVO: The NCVO is a leading voice for the voluntary sector in the UK. Established in 1919, NCVO champions the work of charities, community groups, and voluntary organisations, providing them with a platform to collectively address challenges and amplify their impact. This membership places PatientsCann in a vibrant network of over 15,000 member organisations, ranging from small community groups to well-established charities. The Value of NCVO Membership for PatientsCann: Networking and Collaboration: Joining NCVO opens doors to a diverse community of organisations working towards social change. This network provides opportunities for collaboration, knowledge sharing, and building alliances within and beyond the medical cannabis sector. Advocacy Amplification: NCVO is a powerful advocate for the voluntary sector, influencing policies and decisions at the national level. By aligning with NCVO, PatientsCann gains a stronger voice in shaping policies that directly impact medical cannabis patients and the industry. Capacity Building: NCVO offers a wealth of resources, training, and support to enhance the effectiveness and impact of voluntary organisations. This invaluable support will empower PatientsCann to further its mission of educating, advocating, and supporting the medical cannabis community. Policy Engagement: As an NCVO member, PatientsCann gains access to valuable insights on policy developments and changes affecting the voluntary sector. This knowledge is crucial for steering our advocacy efforts in a rapidly evolving medical cannabis landscape. Implications for the Medical Cannabis Community: Our membership with NCVO is not just a milestone for PatientsCann; it’s a win for the entire medical cannabis community. It elevates the visibility of medical cannabis advocacy within broader discussions on healthcare, patient rights, and social well-being. Looking Ahead: As we embark on this exciting journey with the NCVO, we are filled with gratitude for the continued support of our community. Together, we will continue to strive for a future where medical cannabis patients are informed, empowered, and treated with the dignity they deserve. Stay tuned for more updates, and thank you for being an essential part of the PatientsCann community.
The post PatientsCann UK Joins Forces with the NCVO: Elevating Medical Cannabis Advocacy first appeared on PatientsCann UK.
The Sanskara Platform (now PatientsCann UK) and Seed Our Future Co-Author Report with Cannabis Industry Council Urging Employers to Support Prescription Cannabis Patients 07/11/2023 – The Sanskara Platform, in collaboration with Seed Our Future, is pleased to announce the release of an important report addressing the rights of prescription cannabis patients in the workplace. This ground-breaking report, titled ‘The Use of Prescription Cannabis at Work,’ has been authored by Mohammad I Wasway, Founder of The Sanskara Platform, and Guy Coxall, Founder of Seed Our Future. It forms a crucial part of the Standards Working Group within the Cannabis Industry Council (CIC). The report, highlighted by the CIC, reveals a pressing issue affecting prescription cannabis patients and their rights in the workplace. It suggests that current employer practices may put them at risk of breaching the Equality Act. The Act mandates that employers must make reasonable adjustments to accommodate individuals with disabilities, which includes many prescription cannabis patients who often suffer from chronic pain and disabilities. The CIC’s report underscores the necessity for employers to treat prescription cannabis patients just like any other medical patients, aligning with their legal obligations under the Equality Act 2010 and the Health and Safety at Work Act 1974. Report co-authors, Mohammad Wasway and Guy Coxall, expressed their concerns, stating, “We have heard from many concerned and vulnerable patients who have been harassed and mistreated by their employers simply for taking their prescription medication. We urge businesses to support their employees and implement sensible and proportionate solutions that will improve employee wellbeing and productivity.” Elisabetta Faenza, Chair of the CIC Standards Working Group, emphasised the Council’s commitment to upholding workplace rights for prescription cannabis patients, asserting, “The Cannabis Industry Council will be working with employers and unions to uphold workplace rights for prescription cannabis patients, based on law, medicine, and basic compassion. Many businesses say they are committed to equality, diversity, and inclusivity, yet often underdeliver. Now is the time for employers to step up and support ill and disabled employees.” The report not only sheds light on the medical context surrounding prescription cannabis but also suggests ways to manage its usage by employees. It includes user-friendly flowcharts and illustrative case studies to help employers navigate this complex issue. Since 2018, specialist doctors have had the authority to prescribe cannabis medicines to their patients, who are then legally permitted to possess and consume this medication. Employers who fail to uphold the workplace rights of patients, including both employees and job applicants, face the risk of being taken to an employment tribunal. This report is a significant step towards ensuring that prescription cannabis patients receive fair treatment and protection under the law. It calls upon employers to support their employees’ medical needs and uphold the principles of equality, diversity, and inclusivity in the workplace. Read the report here
The post Use of Prescription Cannabis at Work first appeared on PatientsCann UK.
https://www.protectourpatients.co.uk/ In the realm of medical cannabis, a significant disparity exists between patients’ needs and their access to appropriate treatments. While progress has been made, with the UK government allowing specialists to prescribe cannabis medicines in 2018, a critical challenge remains: general practitioners (GPs) are still unable to prescribe this potentially life-changing therapy. As a consequence, a staggering 1.8 million individuals in the UK are compelled to turn to the illicit cannabis market for medical reasons. This is further exacerbated by the financial strain faced by those on low incomes, who struggle to afford private prescriptions. It’s high time we address these issues and embark on a transformative journey to protect our patients and enhance healthcare outcomes. The ‘Protect our Patients’ campaign is a groundbreaking initiative aimed at rectifying the inequity surrounding medical cannabis prescriptions. Its core mission is to advocate for GPs to be granted the same prescribing rights as consultants, thus empowering them to effectively support their patients in need. By removing the existing barriers, we can ensure that every individual, regardless of their socioeconomic background, has access to safe and effective cannabis-based treatments. In 2018, the UK government acknowledged the therapeutic potential of cannabis medicines and legalised their prescription. However, this progressive step fell short in one crucial aspect: GPs were excluded from the regulatory framework, limiting their ability to provide comprehensive care to their patients. This oversight has resulted in a significant gap in access to medical cannabis, forcing patients to navigate the illicit market or face financial hardship to obtain private prescriptions. GPs serve as the first point of contact for patients, entrusted with their comprehensive healthcare. By granting them the authority to prescribe cannabis medicines, we open doors to a range of benefits: The time has come to bridge the gap in patient care and advocate for the empowerment of GPs to prescribe medical cannabis. Together, let’s protect our patients and ensure equitable access to life-changing treatments. Visit ProtectOurPatients.co.uk to learn more about the campaign, get involved, and be part
The post Empowering GPs to ‘Protect our Patients’: Join the Campaign! first appeared on PatientsCann UK.
Are you planning to travel abroad with medical cannabis from the UK? It can be a daunting task to navigate the various regulations and import laws of each destination country. Fortunately, PatientsCann has compiled a comprehensive guide to help you with the process. PatientsCann is an online resource that provides guidance on medical cannabis for patients, caregivers, and healthcare professionals. They have recently released a new table of information that outlines the regulations for importing medical cannabis into several popular British holiday destinations. The table provides a detailed breakdown of the import laws and regulations for each country, along with contact information for the relevant embassy departments. This makes it easier for patients to plan their travel and ensure they have the necessary documentation and permissions to bring their medication with them. It is important to note that each country has its own regulations, and it is essential to consult with the relevant embassy or consulate before travelling. PatientsCann’s guide can serve as a starting point, but it is not a substitute for professional legal advice. If you are planning to travel abroad from the UK with a medical cannabis prescription, make sure to check out PatientsCann’s table of information. It can be accessed via their website at https://patientscann.org.uk/travel/. Medical cannabis is a rapidly growing industry and has proven to be effective in treating various health conditions. However, different countries have varying regulations regarding the importation of medical cannabis. PatientsCann has created a table of information that outlines the necessary details and contact details/links for the importation of medical cannabis into popular British holiday destinations. Australia, Bahamas, Belgium, Bermuda, Czech Republic, Greece, Hungary, Italy, Jamaica, Netherlands, Romania, Spain, Sweden, Thailand, Trinidad & Tobago, and Turkey are included in the table. Among these countries, Germany, Poland, and Portugal allow for the importation of medical cannabis for personal use with certain conditions, among many others. Germany permits the importation of cannabis for personal use if prescribed by a doctor on the German list of narcotics. The patient is required to complete a form similar to the provided template and obtain confirmation from the supervising health authority of the patient’s county/area of residence. The patient can carry the cannabis for up to 30 days. In Poland, a patient may bring medicines to the country for personal use not exceeding five smallest packages. However, the patient needs to complete a document for import/export of narcotic drugs/psychotropic substances for medical needs and obtain consent from the Chief Pharmaceutical Inspectorate. In Portugal, patients can bring a higher amount of medication than required for the stay to anticipate unforeseen events. For medicines containing controlled substances, including cannabis, patients can bring only the amount required for 30 days of treatment with a medical justification/doctor’s statement. Patients are advised to contact the authority responsible for Customs and/or Civil Aviation in their country to find out the necessary documents required to transport medical cannabis. Greece allows visitors to bring products for personal health use, such as medicines, food supplements, antiseptics, cosmetics, medical devices, etc., for personal use during their stay. However, visitors are required to bring just enough of each product to cover their needs during their stay and hold a letter from their doctor stating the medication(s) they are carrying. Overall, it is essential to research and understand the regulations of the destination country regarding the importation of medical cannabis before travelling. PatientsCann’s table of information provides a valuable resource for individuals travelling to popular British holiday destinations with medical cannabis needs. TRAVEL ABROAD
The post Your Guide to Taking Medical Cannabis on Your Next Holiday first appeared on PatientsCann UK.
This membership is aimed to improve patient outcomes in the medical cannabis industry.
The post PatientsCann UK (formally Sanskara) Continues Their Membership With The Cannabis Industry Council first appeared on PatientsCann UK.
Following the recent legalisation of medical cannabis in Ukraine, Adam Kavalier PhD, explores what we know about its potential in the treatment of PTSD. Ukrainian President Volodymyr Zelensky recently signed into law reforms on medical Cannabis to provide relief to victims of trauma, resulting from the [...]
A medical cannabis patient has been cleared of charges against him on the grounds that he has a legal prescription, after being pulled over by police for a second time. Nathan Williams was found not guilty of failure to provide a specimen at Welshpool Magistrates Court [...]
Via Business of Cannabis Germany’s Bundesrat (Federal Council) has voted to pass the CanG bill without calling in a mediation committee, meaning the law should come into effect on 1 April, 2024. In perhaps the most important vote on cannabis liberalisation in European history, the German [...]
Curaleaf International, a market-leading global cannabis company, has been announced as the Headline Partner for Cannabis Europa, scheduled to take place in London on 25-26 June, 2024. Cannabis Europa is Europe’s foremost conference series that connects influential leaders in science, policy and business, helping to build [...]
Via Business of Cannabis Portugal’s cannabis regulator has approved three new cannabis preparations for its medical cannabis programme, marking the first expansion since 2021. Since voting to legalise medical cannabis in 2018, Portugal has only seen one cannabis preparation be approved by INFARMED (Instituto Nacional de [...]
Switzerland has launched its seventh adult-use cannabis pilot, the largest to date, following the publication of the first trial data earlier this month. Officials in Switzerland announced a seventh pilot study into the sale of legal cannabis for adult-use in the district of canton Zürich on [...]
Over the past century, numerous pivotal concepts have emerged, shaping the course of society and enhancing our collective well-being. Among these, Good Manufacturing Practices (GMPs) stand out as a beacon of assurance for product safety and consumer protection. Prior to the establishment of GMPs, industries such [...]
The first study of its kind has found cannabis to be beneficial in the treatment of female orgasm disorder. For the first time researchers have investigated the effects of cannabis in treating female orgasm disorder/difficulty (FOD), with the results demonstrating ‘significant benefit’. While previous research has [...]
What’s it like working as a toxicologist in the CBD industry? Cristelle Santos, consultant toxicologist at Broughton Group, shares her experience. With many new novel food products that contain CBD coming to market, extensive toxicology testing is vital to assess possible risks associated with the ingredients, [...]
Newly-published real-world evidence finds medical cannabis to be effective in managing symptoms of PTSD and comorbid depression. There has been increasing interest in using cannabis-based medicines in the treatment of PTSD, particularly in the veteran population. Most notably, Ukraine recently legalised medical cannabis with President Zelensky [...]
Via Business of Cannabis The French National Medicines Safety Agency (ANSM) has confirmed that flowers will not be included in its upcoming generalised medical cannabis framework. While not wholly unexpected, the abrupt nature and failure of the ANSM to provide any viable alternative to patients currently [...]
Early economic analysis suggests that cannabis-based medicines may be a cost-effective treatment for managing chronic pain. Initial findings from a small feasibility study suggest that at the right price point, cannabis-based medicines could offer a cost-effective alternative for the treatment of chronic pain, if prescribed on [...]
The former Wimbledon tennis champion, Pat Cash, has described CBD oil as a ‘gamechanger’ for athletes living with chronic pain as he launches his own range of products. The 1987 Wimbledon Men’s Singles tennis champion announced this month on the popular Australian television chat show The [...]
Now that Ukrainian President Volodymyr Zelenskiy has signed a law opening access to medical cannabis, Ukraine has joined a list of emerging countries that recognize the benefits of this plant for their people, writes Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals. Recently, the United States Department of [...]
Cannabis products high in CBD can ease anxiety better than THC-dominant products, new research suggests. A study of 300 people, published in the journal Cannabis and Cannabinoid Research, is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms. The study, led [...]
Almost six years since the law changed, children still struggle to access a consistent supply of cannabis-based medicine in the UK. With families now facing national shortages of other anti-epileptic drugs, it’s time the sector stepped up, writes co-founder and director, Matt Hughes, Medcan Family Foundation. [...]
In an extract from the handbook, Principles of Clinical Cannabinology, Viola Brugnatelli and Fabio Turco explore the cutaneous Endocannabinoid System and its potential applications in treating various dermatological conditions. The skin, the body’s largest organ, serves not only as a protective barrier but also plays crucial [...]
New findings suggest that cannabis could reduce reliance on other stimulant drugs, and play a role in addressing the ongoing opioid overdose crisis. A new study at the University of British Columbia has observed that using cannabis is associated with decreased use of crystal methamphetamine among [...]
In mid-January, against the backdrop of Kentucky’s renowned reputation for fast horses and whiskey, dozens of experts, advocates, operators, and regulators dove headfirst into the heartbeat of innovation and regulation at the ASTM Committee Week. It was my very first time attending, and I waded right [...]
A seven year wait has finally come to an end for patients in Greece, as the first legal medical cannabis prescriptions were issued this week. A 60-year-old mother of three, Anna Paga, who has psoriatic arthritis, became one of the country’s first patients to receive a [...]
Via Business of Cannabis Spain’s Ministry of Health has launched a public consultation on its proposals for a medical cannabis framework in the country. Organisations and individual citizens will now have until 4 March to submit their comments on the proposals, as Spain’s new government makes [...]
Back in 2020, the European Commission formally classified edible cannabidiol (CBD) products like gummies, drinks, oils and even bread as novel foods (NFs). Today, all submitted applications remain on hold, with no CBD products receiving NF authorisation in the UK or Europe. Here Libby Clarke, managing [...]
From 26th February, the medical cannabis division of Rokshaw Ltd is rebranding to Curaleaf Laboratories. Since its inception in 2012 by founders Jonathan and Richard Hodgson, Rokshaw has created an industry wide reputation of providing the highest quality of products from our MHRA-approved manufacturing facility. Its [...]
High-quality cannabis on the medical market is the holy grail among both patients and clinics with heart. There’s still a fair bit of catching up to do before the UK can offer a selection of medication options that rivals other areas of the world. But one [...]
Patients from across the globe will call for fair and equal access to medicinal cannabis treatment at the upcoming session of the UN Commission on Narcotic Drugs. Members of the IACM Patient Council, alongside other non-profit organisations, will represent the rights of patients seeking legal, fair [...]
A new study has found few changes in driving performance among patients taking medicinal cannabis products. Researchers at Swinburne University in Australia examined the effects of cannabis products on simulated driving performance in a group of 40 patients legally prescribed medical cannabis. The semi-naturalistic study found [...]
A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates in skin cancer, a new in-vitro study has found. Researchers from Charles Darwin University (CDU) and RMIT investigated programmed cell death caused by a specific extract (cannabinoid PHEC-66) [...]
Via Business of Cannabis The Irish Government has approved the establishment of an Oireachtas committee to examine the Citizens’ Assembly recommendations for the decriminalisation of drug use ‘as quickly as possible’. It comes just two weeks after the Dáil, Ireland’s lower parliamentary house, voted to delay [...]
Glaucomas constitute a group of eye disorders characterized by progressive damage to the optic nerve, often associated with increased intraocular pressure (IOP), leading to irreversible vision loss. Glaucoma can develop slowly, and the gradual vision loss may go unnoticed for an extended period. Regular eye examinations, [...]
President Zelensky has signed a bill legalising medical cannabis in Ukraine, with patients expected to have access to regulated medicines as early as 2024. In what has been described as a ‘great victory’, on Tuesday 13 February, President Zelensky signed into law legislation permitting the prescription [...]
As reported by Business of Cannabis The European Commission (EC) last week partially approved a new ‘European Citizens Initiative’ focused on cannabis reform, in a move marking an increasing acknowledgment of the changing landscape in regards to cannabis regulation across the European Union (EU). This [...]
Jersey lawmakers have passed new legislation which is described as a ‘step towards’ the decriminalisation of possession of small amounts of cannabis and other Class B and C drugs. In a vote on Wednesday 7 February, the Jersey States Assembly unanimously approved an amendment to the [...]
In a new study, 38% of dog owners surveyed in Denmark reported giving their pups cannabinoids, with 77% reporting at least some ‘positive effect’. In recent years, cannabis has become more widely used for recreational and medical use in humans, and many cannabis-based products are also [...]
The number of Israeli patients using medical cannabis is set to increase significantly by 2027 as imminent policy reforms will make it easier for patients to access cannabis-based treatments, a new report has found. As of December 2023, 30 years after the Ministry of Health issued [...]
Via Business of Cannabis Spain’s newly appointed health minister has said that the country’s long-awaited medical cannabis law will be ready ‘in the coming months,’ as she makes good on her promise to kickstart progress. Mónica García Gómez used her first appearance in Congress to reaffirm [...]
In a new extract from the Principles of Cannabinology Handbook, Viola Brugnatelli and Fabio Turco, examine whether cannabis could play a role in tackling the global obesity crisis. Obesity has evolved into a significant public health crisis, with alarming global prevalence rates and with profound health [...]
The Cannabis Industry Council (CIC) has committed to supporting UK veterans in accessing medicines for conditions such as PTSD and chronic pain. Leaders at the CIC have joined over 11,000 other organisations across the country in signing the Armed Forces Covenant, which pledges to support the [...]
New studies challenge some longstanding myths about cannabis and its effects on driving and motivation, while others examine cognitive function, cancer and CBD in cats In recent weeks new research has been published exploring the relationship between cannabis and driving impairment, motivation and cognitive function in [...]
Via Newsweed The Danish Medicines Agency has published the latest findings from the country’s ongoing medical cannabis pilot programme. Denmark launched its medicinal cannabis pilot programme in 2018, allowing doctors to prescribe cannabis-based products for patients with certain qualifying conditions. Now officials have published the latest [...]
Ireland’s Health Research Board (HRB) has published the findings from its review of evidence for the safety and efficacy of prescribed medicinal cannabis. The report, which was published on Tuesday 23 January, found evidence to support the use of prescribed medicinal cannabis for certain conditions for [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
